Suleiman Mohammed, Tang Patrick, Imam Omar, Morales Princess, Altrmanini Diyna, Roberts Jill C, Pérez-López Andrés
Department of Pathology, Sidra Medicine, Doha P.O. Box 26999, Qatar.
Department of Pathology and Laboratory Medicine, Weill Cornell Medicine in Qatar, Doha P.O. Box 24144, Qatar.
Microorganisms. 2024 Aug 28;12(9):1785. doi: 10.3390/microorganisms12091785.
The diagnosis of infection (CDI) in the pediatric population is complicated by the high prevalence of asymptomatic colonization, particularly in infants. Many laboratory diagnostic methods are available, but there continues to be controversy over the optimal laboratory testing approach to diagnose CDI in children. We evaluated commonly used diagnostic commercial tests in our pediatric hospital population at Sidra Medicine in Doha, Qatar. Between June and December 2023, 374 consecutive stool samples from pediatric patients aged 0-18 years old were tested using: Techlab Quik Chek Complete, Cepheid GeneXpert , QIAstat-Dx Gastrointestinal Panel, and culture using CHROMagar . The results of these tests as standalone methods or in four different testing algorithms were compared to a composite reference method on the basis of turnaround time, ease of use, cost, and performance characteristics including specificity, sensitivity, negative predictive value, and positive predictive value. Our study showed variability in test performance of the different available assays in diagnosing CDI. In our population, a testing algorithm starting with Cepheid GeneXpert PCR assay or QIAstat-Dx Gastrointestinal panel as a screening test followed by toxin immunoassay for positive samples using the Techlab Quik Chek Complete kit showed the best performance (100% specificity and 100% positive predictive value) when combined with clinical review of the patient to assess risk factors for CDI, clinical presentation, and alternative causes of diarrhea.
在儿科人群中,感染性腹泻(CDI)的诊断因无症状定植的高发生率而变得复杂,尤其是在婴儿中。有许多实验室诊断方法可用,但在诊断儿童CDI的最佳实验室检测方法上仍存在争议。我们在卡塔尔多哈的Sidra Medicine儿童医院对常用的诊断性商业检测进行了评估。在2023年6月至12月期间,使用Techlab Quik Chek Complete、Cepheid GeneXpert、QIAstat-Dx胃肠道检测板以及使用CHROMagar进行培养,对374例0至18岁儿科患者的连续粪便样本进行了检测。将这些检测作为独立方法或四种不同检测算法的结果,在周转时间、易用性、成本以及包括特异性、敏感性、阴性预测值和阳性预测值在内的性能特征方面,与一种综合参考方法进行了比较。我们的研究表明,不同现有检测方法在诊断CDI时的检测性能存在差异。在我们的人群中,一种检测算法以Cepheid GeneXpert PCR检测或QIAstat-Dx胃肠道检测板作为筛查试验,随后使用Techlab Quik Chek Complete试剂盒对阳性样本进行毒素免疫测定,当与对患者的临床评估相结合以评估CDI的危险因素、临床表现和腹泻的其他原因时,表现出最佳性能(100%特异性和100%阳性预测值)。